The problem of pressure elevation associated with intravitreal triamcinolone
- PMID: 16854833
- PMCID: PMC1857193
- DOI: 10.1136/bjo.2006.093310
The problem of pressure elevation associated with intravitreal triamcinolone
Abstract
A question remains about the relation between the amount of drug in the vitreous cavity and the intraocular pressure elevation and duration
Comment on
-
Intraocular pressure alterations following intravitreal triamcinolone acetonide.Br J Ophthalmol. 2006 Aug;90(8):999-1003. doi: 10.1136/bjo.2006.090340. Epub 2006 Apr 5. Br J Ophthalmol. 2006. PMID: 16597664 Free PMC article.
References
-
- McCuen B, Bressler N, Tano Y.et al The lack of toxicity of intravitreally administered triamcinolone acetonide. Am J Ophthalmol 198191785–788. - PubMed
-
- Danis R P, Bingaman D P, Yang Y.et al Inhibition of preretinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide. Ophthalmology 19961032099–2104. - PubMed
-
- Challa J K, Gillies M C, Penfold P L.et al Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up. Aust N Z J Ophthalmol 199826277–281. - PubMed
-
- Martidis A, Miller D G, Ciulla T A.et al Corticosteroids as an antiangiogenic agent for histoplasmosis‐related subfoveal choroidal neovascularization. J Ocul Pharmacol Ther 199915425–428. - PubMed
-
- Martidis A, Duker J S, Greenberg P B. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002109920–927. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical